In theory, it is indeed feasible to design a viral vector for delivering gene editing tools, and some progress has been made in the field of scientific research and gene therapy. For example, viral vectors such as adenovirus, lentivirus, and adeno-associated virus (AAV) have played an important role in gene delivery. However, to affect a specific population on a large scale, there are multiple complex ethical, legal, and safety issues involved: 1. **Ethical issues**: The dissemination of gene editing tools in the population may raise ethical disputes, including informed consent and potential involuntary intervention. 2. **Technical challenges**: It is very difficult to design viral vectors to infect target cells efficiently and specifically while reducing the impact on non-target cells. 3. **Safety**: Viral vectors may cause adverse reactions or side effects, such as immune responses or genomic instability. 4. **Laws and regulations**: Many countries have strict regulations on gene editing technology, especially those involving modifications to the human genome. In summary, although it is technically possible to design such a viral vector, the ethical and safety issues that must be considered in practical applications are very complex. When conducting such research, relevant scientific and ethical norms must be followed to ensure public safety and respect for individual rights.